Enhancement of beta-catenin in cardiomyocytes suppresses survival protein expression but promotes apoptosis and fibrosis by Lin, James C. et al.
Address for correspondence: Chih-Yang Huang, PhD, Graduate Institute of Basic Medical Science, Graduate Institute of 
Chinese Medical Science, China Medical University and Hospital, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan,  
tel: +886-4-2205-3366 ext. 3313, fax: +886-4-2207-0465, e-mail: cyhuang@mail.cmu.edu.tw
*These authors have equally contributed to this publication.
Received: 28.06.2016 Accepted: 20.09.2016
Enhancement of beta-catenin in cardiomyocytes 
suppresses survival protein expression but  
promotes apoptosis and fibrosis
James C. Lin1, 2, Wei-Wen Kuo3, Rathinasamy Baskaran4, Ming-Cheng Chen5,  
Tsung-Jung Ho6, 7, Ray-Jade Chen8, Ya-Fang Chen9, Viswanadha Vijaya Padma10,  
Ing-Shiow Lay6, 7,*, Chih-Yang Huang4, 6, 11,*
1Department of Occupational Therapy, Asia University, Taichung, Taiwan 
2Department of Internal Medicine, Cheng Ching Hospital, Taichung, Taiwan  
3Department of Biological Science and Technology, China Medical University, Taichung, Taiwan 
4Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan 
5Division of Colorectal Surgery, Department of Surgery,  
Taichung Veterans General Hospital, Taichung, Taiwan 
6School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan 
7Chinese Medicine Department, China Medical University Beigang Hospital, Yunlin County, Taiwan 
8Department of Surgery, School of Medicine, College of Medicine,  
Taipei Medical University, Taipei, Taiwan 
9Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung, Taiwan 
10Department of Biotechnology, Bharathiar University, Coimbatore, India 
11Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan
Abstract
Background: Beta-catenin has been implicated in cell-cell communication in a wide variety of  
developmental and physiological processes. Defective Wnt signaling could result in various cardiac  
and vascular abnormalities. Little is known regarding Wnt/frizzled pathway in cardiomyocyte  
apoptosis.
Methods: In this study, the role of b-catenin in apoptosis was investigated in H9c2 cardiomyocytes 
and primary cardiomyocytes isolated in diabetic Wistar rats. The cardiomyocytes were transfected with 
porcine cytomegalovirus (pCMV)-b-catenin plasmid in order to overexpress b-catenin.
Results: The transcription factor displayed a significant nuclear localization in Wistar rats with 
cardiac hypertension. Transfection of b-catenin plasmid induced apoptosis and reduced expression of 
survival pathway markers in cardiomyocytes in a dose-dependent manner. Furthermore, expression of 
fibrosis protein markers was upregulated by the overexpression.
Conclusions: Taken together, these results revealed that altered Wnt/b-catenin signaling might provoke 
heart failure. (Cardiol J 2017; 24, 2: 195–205)
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Introduction
In several studies, it was shown that humoral 
factors secreted by mechanically stressed car-
diomyocytes activate a vast network of intra- and 
intercellular transduction signals that act in an au-
tocrine or paracrine fashion. These factors are able 
to alter myocardial ultrastructure and determine 
cardiac fibroblast hypertrophy and/or apoptosis, 
mesenchymal fibrotic, inflammatory processes and 
can alter cardiac gene expression [1–5]. This series 
of events is the basis of myocardial remodeling [6], 
which is a complex phenomenon of ultrastructural 
cardiac rearrangement. Because of the sensible 
changes in cardiomyocyte viability, energy metabo-
lism and kinetic and electrical properties, as well 
as in cytoskeletal and extracellular matrix compo-
sition, myocardial remodeling is considered a key 
pathogenetic factor of chronic heart failure and of 
its natural history, which is marked by inexorable, 
progressive cardiac dysfunction [7–9].
Cardiac hypertrophy is a fundamental process 
of adaptation to an increased workload due to 
hemodynamic overload [10–12]. Development of 
cardiac hypertrophy is a compensatory response 
because it augments the number of contractile 
units and reduces ventricular wall stress to normal 
levels in accordance with Laplace’s Law. Prolonged 
myocardial hypertrophy triggered by chronic over-
load may damage the heart over time. Increased 
ventricular wall thickness initially reduces parietal 
stress, oxygen requirement and increases heart 
contractility. However, this compensatory effect 
is markedly curbed by subsequent expression of 
pro-apoptotic embryo-fetal genes and fibroblastic 
hyperplasia with increased collagen synthesis 
caused by the same biochemical mediators which 
determine hypertrophy. Loss of contractile tissue 
due to cardiomyocyte apoptosis and mesenchymal 
fibrosis is determined by increased collagen syn-
thesis, causingthe heart to dilate and stiffen, which 
results in systolic and diastolic dysfunction [13].
Beta-catenin has been implicated in cell-cell 
communication in a wide variety of developmental 
and physiological processes. Wnt/b-catenin signal-
ing is required for different aspects of cardiac and 
vascular developments. Defective Wnt signaling 
can result in various cardiac and vascular abnor-
malities. In the adult heart and blood vessels, 
activity of the signaling pathway is quite low un-
der normal conditions. However, it is reactivated 
during pathological cardiac remodeling induced 
by pressure overload to injured arteries and after 
myocardial infarction [14].
In recent years, b-catenin signaling has been 
clearly shown to be involved in hypertrophic growth 
[15]. In contrast, little is known regarding Wnt/friz-
zled pathway in cardiomyocyte apoptosis. In other 
mammalian cell types, overexpression of b-catenin 
promotes apoptosis [16–18]. In a previous study, it 
was demonstrated that b-catenin was increased in 
cardiomyocytes of spontaneously hypertensive heart 
failure in rats compared with an age-matched control 
group [19]. In another study, it was indicated that 
when heart injury occurs, Wnt signaling activates and 
induces cardiac fibrosis [20]. Moreover, transfection 
with b-catenin-specific small interfering RNA or ex-
pression of dominant-negative T cell factor inhibited 
apoptosis, whereas expression of dominant stable 
b-catenin caused significant apoptosis in human ovar-
ian surface epithelial cells [21]. Similar results were 
also obtained in human T/C28a cell line [22], indicat-
ing pro-apoptotic roles for b-catenin and T cell factor.
Wnt/frizzled pathway is known to be involved in 
fibrosis of several organ systems (lungs, kidneys and 
liver) [23–26]. WNT1 and WNT10B are upregulated 
in pulmonary fibrosis and in liver cirrhosis [23]. In 
cardiomyocytes, cardiac fibroblasts are regulated in 
vitro by Wnt signaling cascade [27]. Specific com-
binations of Wnt ligands and frizzled elicit distinct 
responses. In vivo, pediatric heart allographs with 
diastolic dysfunction and severe epicardial fibrosis 
display nuclear b-catenin accumulation in fibro-
blasts, suggesting activation of Wnt signaling [28].
The present study aims to investigate the role 
of b-catenin in apoptosis, fibrosis and survival in 
cardiomyocytes. 
Methods
Human cardiovascular tissue microarray
Tissue microarray used in this study was 
purchased from Provitro (Berlin, Germany) com-
prises heart specimens of normal tissue (n = 10) 
and myocardial scar tissue (n = 10). These tissues 
were collected from females and males with an age 
range of 25–84 years old. Infarct locations included 
anterior, posterior and septal segments. Normal 
tissues included both left and right ventricles. Only 
the former was used for analysis.
The study procedures conformed to the ethical 
guidelines of the 1975 Declaration of Helsinki and 
were reviewed and approved by the Institutional 
Review Board of the Armed Force Taichung Gen-
eral Hospital, Taichung and the China Medical 
University, Taichung, Republic of China. Verbal 
and written informed consents for inclusion in the 
study were obtained prior to sample collection.
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Diabetic rat model
Male Wistar rats of 6 weeks old were obtained 
from the National Laboratory Animal Center, Tai-
wan. Ambient temperature was maintained at 25°C 
and the animals were kept on an artificial 12-h light-
dark cycle. The rats were provided with standard 
laboratory chow (PMI Nutrition International Inc., 
Brentwood, MO, USA) and water ad libitum. 
Streptozotocin (STZ) was previously shown to 
induce diabetes in rats [29–32]; therefore, it was 
administered in the animal model. All animals were 
acclimatized to the lab conditions for 1 week after 
their arrival prior to the experiment. All rats were 
randomly assigned into two groups, i.e., control 
group and STZ group. STZ group were injected with 
intraperitoneal injection of STZ (65 mg/kg body 
weight in citrate buffer [pH 4.5]), and control ones 
were injected with an equal volume of vehicle. Rats 
which were considered diabetic displayed fasting 
glucose levels at > 11.1 mM or > 200 mg/dL at 
48 h after STZ injection, these were detected with 
AccuSoft test strips (Roche Diagnostics GmbH, 
Mannheim, Germany).
Immunohistochemistry
Tissue biopsies from human patients described 
in the Human Cardiovascular Tissue Microarray 
section were gathered and fixed with 10% buffered 
formalin for 1 overnight, embedded in paraffin and 
sectioned to 4 μm-thick fractions. The tissue biop-
sy samples were dried at 58°C overnight and then 
dewaxed in xylene for 40 min and rehydrated using 
graded series of ethanol solutions. Endogenous 
peroxidase activity was blocked by incubating in 
hydrogen peroxide blocking buffer (3% H2O2) for 
13 min. After the samples were rinsed in tap water 
for 15 min, the microarray biopsies were microwave-
treated with pre-warmed citrate buffer (0.01M cit-
ric acid [pH 6.0]) for 15 min and then cooled down 
to room temperature (RT) for 30 min. Nonspecific 
binding was blocked with 5% cosmic calf serum 
(CCS; HyClone Laboratories Inc., South Logan, 
UT, USA) for 1 h and then incubated with primary 
antibody directed against b-catenin (1:100 dilution; 
Santa Cruz Biotechnology Inc., TX, USA) at RT 
for 1 overnight. Then, the samples were incubated 
with anti-mouse horseradish peroxidase (HRP) 
secondary antibody (1:100 dilution; Santa Cruz 
Biotechnology Inc., Dallas, TX, USA) at RT for 1 h. 
Immunoreactivity was visualized following incuba-
tion with 3,3’-diaminobenzidine (DAB) substrate 
(Roche Diagnostics GmbH, Mannheim, Germany) 
for 5 min. After the samples were washed with 
1 × phosphate-buffered saline (1 × PBS; GIBCO, 
Auckland, New Zealand) for 10 min, the microarray 
was observed under a microscope (magnification: 
200×) (Olympus, Tokyo, Japan).
Tissue extraction
Diabetic Wistar rat tissue samples were ho-
mogenized for protein extraction in lysis buffer 
(20 mM Tris-base [pH 7.4], 2 mM EDTA, 50 mM 
b-mercaptoethanol and protease inhibitor tablets) 
at a concentration of 100 mg tissue/mL buffer. 
The homogenates were placed on ice for 10 min 
and then centrifuged at 13000 g for 40 min. The 
supernatants were collected separately and stored 
at –80°C for further analysis.
Cell culture
H9c2 cardiomyoblasts were purchased from 
American Type Culture Collection (ATCC) (Ma-
nassas, VA, USA) and were cultured in 100-mm 
dishes in Dulbecco’s modified Eagle’s medium 
(DMEM; Sigma, St. Louis, MO, USA) supple-
mented with 10% CCS in humidified air (5% CO2) 
at 37°C. Cell culture medium was replaced 48 h 
after each sub-cultivation. About 3.5 mL PBS was 
used to wash each culture plate or vessel. H9c2 
cells were transfected with b-catenin plasmid in 
a time-dependent and dose-dependent manner.
Transient transfection 
Cells at 50% confluency were placed in 
a fresh culture medium containing serum 2 h before 
transfection. Then pCMV-b-catenin plasmid was 
transfected into the cells for 24 h with PureFec-
tionTM Nanotechnology-based Transfection Reagent 
(System Biosciences, Palo Alto, CA, USA) follow-
ing the manufacturer protocol. In each experiment, 
efficiency of gene overexpression was measured by 
western blot analysis.
Neonatal rat primary  
cardiomyocyte culture
Primary cadiomyocytes were isolated from 
diabetic Wistar rats with Neonatal Rat/Mouse 
Cardiomyocyte Isolation System Kit (Cellutron 
Life Technology, Baltimore, MD, USA). Each 10-cm 
plate was coated with 4 mL SureCoat solution (Cel-
lutron Life Technology, Baltimore, MD, USA) for 
2 h in humidified air with 5% CO2 at 37°C. Hearts 
of diabetic Wistar rats were isolated and incubated 
in digestion solution at 37°C. Each plate was coated 
with extra 5 mL SureCoat for 2 h in humidified 
air with 5% CO2 at 37°C. Then all isolated cells 
were rested in non-coating dishes for 1 h, heart 
fibroblasts were seeded to the bottom of each plate 
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and floating cells were primary cadiomyocytes, 
which were subsequently transferred to pre-coated 
plates. Finally, ventricular cardiomyocytes were 
cultured in DMEM containing 10% CCS. After 
3–4 days, the cells were transfected with b-catenin 
plasmid in a dose-dependent treatment. 
Annexin V-FITC/PI staining
H9c2 cells were seeded at a density of 2 × 105 
cells per 30-mm culture dish and allowed to grow 
to 60–70% confluency. Then, H9c2 cells were 
transfected with a dose-dependent pCMV b-catenin 
plasmid for 24 h. Apoptotic cells were monitored 
with a FACSCanto flow cytometer (BD Pharmingen 
Inc., San Diego, CA, USA) and an Annexin V-FITC 
Apoptosis Detection Kit (BioVision Inc., Milpitas, 
CA, USA). Total cells and supernatants were 
collected, washed and incubated for 15 min with 
1 × binding buffer containing annexin V-conju-
gated fluorescein isothiocyanate and propidium 
iodide (PI). Annexin V-FITC staining was used to 
detect phosphatidylserine (PS) exposure at the 
cell membrane. Cells that have lost membrane in-
tegrity were stained by PI. Annexin V-positive cells 
were considered early apoptotic cells. Annexin V- and 
PI-positive cells were considered late apoptosis or 
necrotic cells, whereas viable cells were unstained.
Western blot analysis
After the treatment cells were re-suspended in 
lysis buffer (50 mM Tris-base [pH 7.5], 0.5M NaCl, 
1 mM b-mercaptoethanol, 1% NP-40, 1% glycerol 
and protease inhibitor tablets). Samples contain-
ing equal amounts of total protein (40 μg) were 
separated by 10% SDS-PAGE and then transferred 
onto polyvinylidene difluoride membranes (Milli-
pore Corp., Billerica, MA, USA). Residual protein 
sites were blocked in 1 × Tween-20/Tris-buffered 
saline (1 × TBS) containing 5% skim milk. Then, 
the membranes were incubated with 1:1000 diluted 
primary antibody solutions in 1 × TBS buffer at 
4°C for at least 1 overnight, depending affinity of 
each antibody. After the primary antibody solutions 
were recycled, blots were incubated with second-
ary antibody solutions 1 × TBS for 1 h.
Primary antibodies against b-actin, p-Akt, 
Bax, b-catenin, caspase-3, caspase-9, COL2A1, 
CTGF, cytochrome C, p-IGF1R, MMP2, MMP9, 
p-PI3K, p-Smad2/3, SP1, TIMP-1, TIMP-2, tPA and 
uPA were purchased from Santa Cruz Biotechnol-
ogy (Dallas, TX, USA). Primary antibody against 
insulin-like growth factor-1 (IGF-1) was purchased 
from Abcam Plc. (Cambridge, United Kingdom). 
Secondary antibodies used in this study (anti-goat-
HRP, anti-mouse-HRP and anti-rabbit-HRP) were 
purchased from Santa Cruz Biotechnology (Dallas, 
TX, USA).
Assay of MMP2 and MMP9 activities  
by gelatin zymography
Activities of MMP2 and MMP9 were assessed 
by gelatin zymography. After neonatal cardiac fibro-
blasts were treated with the pCMVb-catenin plas-
mid in a dose-dependent manner, cell-conditioned 
media were collected. 20 μL of each sample was 
mixed with 5 μL loading dye (10% SDS, 0.5 M Tris-
-HCl [pH 6.8], 50% glycerol, 6.25 g bromophenol 
blue). The resulting mixtures were loaded to 8% 
SDS-PAGE gels containing 0.1% gelatin and run 
at 120 V for 2.5 h. Then, the gels were washed 
in a 2.5% Triton X-100 solution with shaking for 
30 min and incubated in 50 mL reaction buffer 
(40 mM Tris-HCl [pH 8.0], 10 mM CaCl2, and 0.01% 
NaN3) at 37°C overnight before staining with 0.25% 
Coomassie brilliant blue R-250 in 50% methanol 
and 10% acetic acid for 1 h. Quantitative analysis 
was performed after the gels were washed twice 
in a destaining solution (10% acetic acid, 20% 
methanol) for 30 min.
Statistical analysis
Experimental data in this study were given as 
the mean ± standard deviation. Two differences 
in the groups were compared and analyzed by 
Student t-test. To analyze differences in multiple 
groups one-way ANOVA was used and p < 0.05 
was considered significant.
Results
Expression patterns of b-catenin in human 
infarct hearts and disease model hearts
Expression of b-catenin protein in human in-
farct hearts and in diseased animal model hearts 
were detected. Immunohistochemical staining pat-
terns in myocardial infarction specimens from the 
cardiovascular tissue microarray were examined. 
The results showed that b-catenin staining in-
creased and condensed around the increased inter-
stitial space in the myocardial scar tissue (Fig. 1A). 
In previous studies, the authors observed cardiac 
fibrosis and apoptosis in a diabetic animal model 
[19, 31]. In addition, b-catenin protein expression in 
diseased animal models was determined. b-catenin 
protein expression was elevated in diabetic rat 
hearts (Fig. 1B). Therefore, b-catenin pathway 
was elevated when diabetes is present in Wistar 
rats and in humans.
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Transfection of a dose- and time-dependent 
pCMV-beta-catenin plasmid induced  
cardiomyocyte apoptosis
To determine whether b-catenin is able to in-
duce apoptosis in cardiomyocytes, flow cytometry 
and western blot analysis was conducted. When 
a pCMV-b-catenin plasmid was transfected in dose-
dependent and time-dependent manners, expres-
sion of apoptosis protein markers Bax, cytochrome c, 
caspase 3 and caspase 9 showed increased trends 
in neonatal rat cardiomyocytes and H9c2 cardio-
myoblasts (Fig. 2A, B). Moreover, the percentage 
of apoptosis was enhanced in the cells transfected 
with 0.8 μg or 1.0 μg pCMV-b-catenin plasmid 
(Fig. 2C). Caspase 3 protein expression was increa- 
sed in H9c2 cardiomyoblasts transfected with 1.0 μg 
pCMV-b-catenin (Fig. 2D). Therefore, b-catenin 
was capable of inducing apoptosis in cardiomyo-
cytes in dose- and time-dependent manners.
Transfection of a dose- and time-dependent 
pCMV-beta-catenin plasmid reduces the  
expression of survival pathway  
protein markers
To determine whether b-catenin could reduce 
the survival of cardiomyocytes, western blot analysis 
was conducted. When pCMV-b-catenin plasmid was 
transfected into H9c2 and primary neonatal rat car-
diomyocytes in dose- and time-dependent manners, 
expression of the survival pathway protein markers, 
IGF-1, p-IGF-1R, p-PI3K and p-Akt, were reduced 
(Fig. 3). Therefore, b-catenin was able to downregu-
late IGF-1 pathway and survival in cardiomyocytes.
Transfection of a dose- and time-dependent 
pCMV-beta-catenin plasmid increased the  
expression of fibrosis protein markers
Finally, to determine the possibility of induc-
ing fibrosis in cardiomyocytes, gelatin zymography 
and western blot analyses were conducted. Dose-
dependent and time-dependent transfection of 
pCMV-b-catenin plasmid upregulate the fibrosis 
protein markers, CTGF, MMP2, MMP9, p-Smad2/3, 
SP1, TIMP-1, TIMP-2, tPA and uPA, in both neonatal 
Wistar rat cardiomyocytes and H9c2 cardiomyo-
blasts (Fig. 4A, B). It was found that the expression 
of the fibrosis protein markers SP1 and collagen 
II increased in neonatal cardiac fibroblasts alone 
(Fig. 4C). Conditioned media from the transfection of 
dose-dependent pCMV-b-catenin plasmid into neo-
natal cardiac fibroblasts were collected and gelatin 
zymography was performed to measure activities 
of MMP2 and MMP9. The transfection of pCMV-b- 
-catenin plasmid caused increased MMP2 and MMP9 
activities (Fig. 4D). Therefore, b-catenin overex-
pression can also induce fibrosis in cardiomyocytes.
A
B
Figure 1. Analysis of b-catenin expression in left ventricles of human biopsy with myocardial infarction (MI) and dia-
betic animal model; A. Immunohistochemical analysis of b-catenin expression in the increased interstitial space in the 
myocardial scar tissue (brown) from human patients with MI. Left panel: normal tissue. Right panel: myocardial scar 
tissue. Final magnification: 200× (scale bar, 200 μm); B. Western blot analysis was conducted to access the b-catenin 
expression in heart of diabetic Wistar rats; DM — diabetes mellitus; ***p < 0.001 vs. normal (increase). 
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Figure 2. Beta-catenin overexpression induces apoptosis; A. Neonatal rat cardiomyocytes were transfected with 
pCMV-b-catenin for 24 h. Western blot analysis were conducted to investigate effects of dose-dependent pCMVb-
-catenin plasmid transfection in neonatal rat cardiomyocytes; *p < 0.05 vs. control (increase); **p < 0.01 vs. control 
(increase); ***p < 0.001 vs. control (increase); B. H9c2 cells were transfected with a 1 μg/mL pCMVb-catenin plasmid 
for a time-dependent course. Western blot analysis of effects on time-dependent pCMVb-catenin plasmid transfection 
in neonatal rat cardiomyocytes; *p < 0.05 vs. control (increase); ***p < 0.001 vs. control (increase); C. H9c2 cells 
were transfected with a dose-dependent pCMVb-catenin plasmid for 24 h. Flow cytometric analysis of apoptotic cells 
stained by annexin V-FITC in the x-axis and by PI in the y-axis. The Q4 percentile represents the cells in early apoptosis 
and the Q2 percentile represents the cells in late apoptosis and/or necrosis. Representative apoptotic percentiles of Q2 
plus Q4 are shown; D. H9c2 cells were transfected with a dose-dependent pCMVb-catenin plasmid for 24 h. Western 
blot analysis of caspase 3 expression was conducted; ***p < 0.001 vs. control (increase).
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AB
Figure 3. Beta-catenin overexpression decreased the expression of survival pathway protein markers; A. Neonatal rat 
cardiomyocytes were transfected with a dose-dependent pCMVb-catenin plasmid for 24 h. Western blot analysis was 
conducted to access effect of b-catenin overexpression on survival pathway; *p < 0.05 vs. control (decrease); **p < 0.01 
vs. control (decrease); ***p < 0.001 vs. control (decrease); B. H9c2 cells were transfected with 1 μg/mL pCMVb-
-catenin plasmid for a time-dependent course. After transfection, the expression of survival protein markers was 
accessed by western blot analysis; *p < 0.05 vs. control (decrease); **p < 0.01 vs. control (decrease); ***p < 0.001 
vs. control (decrease).
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Figure 4. Beta-catenin overexpression increased the expression of fibrosis protein markers and decreased the expres-
sion of TIMP-2 and TIMP-1; A. Neonatal rat cardiomyocytes were transfected with a dose-dependent pCMV b-catenin 
plasmid for 24 h; *p < 0.05 vs. control (increase); B. H9c2 cells were transfected with a 1 μg/mL pCMV b-catenin 
plasmid in a time-dependent manner. After transfection, expression of fibrosis protein markers were accessed by 
western blot analysis; *p < 0.05 vs. control (increase); **p < 0.01 vs. control (increase); ***p < 0.001 vs. control (in-
crease); C, D. Neonatal cardiac fibroblasts were transfected with a dose-dependent pCMV b-catenin plasmid for 24 h. 
After transfection, the cells were collected and conditioned media were harvested. Western blot analysis and gelatin 
zymography were conducted to access effects of pCMV b-catenin plasmid on fibrosis; *p < 0.05 vs. control (increase).
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Discussion
Certain humoral factors secreted by mechani-
cally stressed cardiomyocytes activate a vast net-
work of intra- and intercellular transduction signals 
that lead to cardiac dysfunctions [1–5]. Although 
such abnormalities can be compensated by cardiac 
hypertrophy, which is a fundamental process of ad-
aptation to an increased workload due to hemody-
namic overload [10–12], loss of contractile tissue, 
cardiomyocyte apoptosis and mesenchymal fibrosis 
will eventually occur [13]. Beta-catenin signaling 
is activated during pathological cardiac remodeling 
induced by pressure overload in injured arteries 
and after myocardial infarction [14]. In addition, it 
was found to induce apoptosis in other mammalian 
cell types [16–18], heart failure in rats [19] and car-
diac fibrosis [20]. However, the role of b-catenin in 
apoptosis, fibrosis and survival in cardiomyocytes 
requires further study.
Factors that may trigger cardiomyocyte apopto-
sis include mechanical forces, oxidative stress and 
hypoxia as well as an unbalanced presence of growth 
factors and cytokines or neurotransmitters [33, 34]. 
Wnt/b-catenin signaling is known to be required for 
different aspects of cardiac and vascular develop-
ment. Defective Wnt signaling can result in various 
cardiac and vascular abnormalities. Moreover, in 
other studies, it was indicated that Wnt signaling 
is involved in cardiovascular diseases coupled with 
ion channels and cardiac hypertrophy [35, 36]. In the 
present study, b-catenin expression was detected in 
human infarct hearts and in diseased animal model 
hearts. The results showed that b-catenin protein 
expression increased and condensed around the 
interstitial space in the myocardial scar tissue. In 
addition, expression levels of the transcription factor 
b-catenin was found to be increased in diabetic rat 
hearts. Thus, b-catenin might play a crucial role in 
apoptosis induction in cardiomyocytes. Expression 
of apoptosis markers (Bax, cytochrome c, caspase 
3 and caspase 9) was upregulated after transfection 
of pCMV-b-catenin plasmid in neonatal rat cardio-
myocytes and H9c2 cardiomyoblasts. Moreover, the 
apoptosis level was found to be elevated by transfec-
tion with pCMV-b-catenin plasmid.
In a recent review, it was reported that trans-
forming growth factor beta 3 (TGFb3) could induce 
fibrosis through Smad and/or b-catenin signaling 
and addressed the role of apoptosis in fibrosis 
[37]. Arrhythmogenic right ventricular dysplasia/
cardiomyopathy (ARVD/C) is an inherited cardiac 
arrhythmia originating in the right ventricle and 
results in heart failure and sudden cardiac death. 
Development of ARVD/C type 1 has been attrib-
uted to differential expression of TGFb3. TGFb3 
Figure 5. Beta-catenin over-expression induces apoptosis and fibrosis by down regulating survival in cardiomyocytes.
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overexpression could have an activating role in 
Wnt/b-catenin pathway. In human renal proximal 
tubular cells, TGFBR2 was shown to dissociate 
from adherent junctions upon TGFb1 activation 
[38]. TGFb3 is also known to bind to the same 
receptor, possibly eliciting a similar process in the 
heart. Incubation with TGFb1 yielded increased 
levels of b-catenin and dissociation of b-catenin 
from adherent junction complexes was observed 
previously [39]. In addition, cytoplasmic b-catenin 
was stabilized by TGFb activity, thereby promot-
ing Wnt/b-catenin signaling [38, 39]. Transfection 
with pCMV-b-catenin plasmid increased fibrosis 
markers (uPA, tPA, MMP2, MMP9) in neonatal 
rat cardiomyocytes and in H9c2 cardiomyoblasts. 
In addition, expression of fibrosis markers SP1 and 
collagen II increased in neonatal cardiac fibroblasts 
alone. Taken together, these demonstrated that 
Wnt/b-catenin pathway could be necessary for 
TGFb-induced fibrosis in cardiomyocytes [23, 24].
Transforming growth factor b signaling has also 
been implicated in both cell growth and apoptosis, 
depending on the concentration of the cytokine 
and on the signaling context. Myocardial cells of 
patients suffering from ARVD/C were shown to 
express and overexpress proapoptotic caspase 3 
and Bax, respectively [40, 41]. In different stud-
ies, hypoxia was shown to induce TGFb activity 
[42–44]. In addition, activities of b-catenin and 
TGFb were shown to be co-related [45–47]. 
Conclusions
In conclusion, Wnt/b-catenin signaling cascade 
is capable of damaging cardiomyocytes and this 
study will provide a clear picture in treatment 
of cardiovascular disease. Strategies of targeting 
b-catenin expression in cardiomyocytes assists in 
preventing heart cells from myocardial infarction-
induced apoptosis, fibrosis and reduced survival.
Highlights
1. Diabetes mellitus caused increased b-catenin 
expression in humans and Wistar rats.
2. Beta-catenin overexpression led to increased 
apoptosis in H9c2 cardiomyoblasts.
3. Beta-catenin resulted in reduced H9c2 cell 
survival.
4. Overexpression of b-catenin up-regulated 
fibrosis markers in H9c2 cardiomyoblasts.
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